NCT04080336View on ClinicalTrials.gov

Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Nulliparous Women

PHASE4CompletedINTERVENTIONAL

Enrollment

129

Participants

Timeline

Start Date

September 10, 2019

Primary Completion Date

December 20, 2019

Study Completion Date

January 20, 2020

Conditions

IUD Insertion Complication

Interventions

DRUG

Dinoprostone

1 vaginal tablet of dinoprostone (3mg) (prostin® E2, Pharmacia \& Upjohn, Puurs, Belgium) inserted by the study nurse 3hours before IUD insertion.

DRUG

Misoprostol

1 vaginal tablet of misoprostol (200mcg) (Misotac®; Sigma Pharma, SAE, Egypt) inserted by the study nurse 3 hours before IUD insertion.

DRUG

placebo

one tablet of placebo inserted by the study nurse 3 hours before IUD insertion.

Trial Locations (1)

11231

Ahmed Samy, Giza

All Listed Sponsors

lead

Cairo University

OTHER

NCT04080336 - Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Nulliparous Women | Biotech Hunter | Biotech Hunter